Table 2

SB and physical activity in the CVD risk groups*

	<10% risk (n=884)	10%–30% risk(n=400)	>30% risk/CVD(n=114)	<10% risk vs10%–30% riskP values	<10% risk vs>30% risk/CVDP values
MVPA
Mean daily accumulated total times of MVPA bouts lasting
>30 s†	46 (0.8)	40 (1.3)	29 (2.3)	0.001	<0.001
>5 min†	16 (0.6)	14 (0.8)	10 (1.7)	<0.001	<0.001
>10 min†	10 (0.5)	9.3 (0.7)	7.1 (1.4)	0.002	0.002
Mean daily number of MVPA bouts lasting
>5 min‡	1.3 (0.04)	1.1 (0.1)	0.8 (0.1)	<0.001	<0.001
>10 min‡	0.48 (0.02)	0.45 (0.03)	0.36 (0.07)	0.001	0.001
>3 min‡	2.6 (0.1)	2.2 (0.1)	1.5 (0.2)	0.003	<0.001
SB
Mean daily accumulated total times of SB bouts lasting
>3 min†	350 (3.7)	374 (5.5)	398 (11.1)	0.006	0.002
>5 min†	308 (3.6)	335 (5.4)	358 (11.0)	0.005	0.004
Mean daily number of SB bouts lasting
>5 min‡	23.1 (0.2)	23.2 (0.3)	24.3 (0.6)	0.028	0.001
>10 min‡	11.5 (0.1)	12.3 (0.2)	13.2 (0.4)	0.014	0.002
Number of daily steps
Maximum	11 070 (160)	9080 (220)	6 670 (430)	<0.001	<0.001
Mean	7 280 (100)	5970 (150)	4 400 (270)	<0.001	<0.001
METs
Maximum peak MET-level of weekly physical activity bouts lasting
15 min	5.8 (0.1)	4.6 (0.1)	3.8 (0.1)	<0.001	<0.001
1 min	8.5 (0.1)	6.5 (0.1)	5.5 (0.2)	<0.001	<0.001
Mean number of breaks in SB
	43.4 (0.4)	40.2 (0.6)	40.3 (1.2)	0.76	0.39

Multinominal regression between the CVD groups. Standardised by age, sex and accelerometer wearing time.
*CVD risk groups: (1) participants with <10% risk of CVD; (2) participants with 10%–30% risk of CVD; (3) participants with >30% risk of CVD or CVD diagnosis (ischaemic heart disease, acute myocardial infarction or combination of these). CVD risk is based on Framingham Risk Score (includes age, systolic blood pressure, total cholesterol, high-density lipoprotein cholesterol, smoking, diabetes and antihypertensive medication as explanatory variables).
†The values denote: minutes (SEM).
‡The values denote: number of bouts (SEM).
CVD, cardiovascular disease; MET, metabolic equivalent; MVPA, moderate-to-vigorous physical activity; SB, sedentary behaviour.